scholarly journals PHP11 REVIEW OF ADJUSTMENT OF ESSENTIAL MEDICINE LIST AT PROVINCIAL LEVEL IN CHINA

2011 ◽  
Vol 14 (3) ◽  
pp. A14 ◽  
Author(s):  
L.W. Shi ◽  
Y.Q. Ma ◽  
L.P. Xu ◽  
D.H. Zhao ◽  
Y. Zhang
Keyword(s):  
Essential Medicine ◽  
Provincial Level ◽  
Essential Medicine List

A STUDY AIMED TO INCREASE THE KNOWLEDGE ABOUT THE FIXED DOSE COMBINATIONS (FDC'S) AND IRRATIONAL FDC'S AVIALABLE IN INDIA.

2021 ◽  
pp. 45-46
Author(s):  
Tauseef Nazir Vaidha ◽  
Sabahat Farooq ◽  
Samina Farhat
Keyword(s):  
Drug Therapy ◽  
Essential Medicine ◽  
Essential Medicines ◽  
Fixed Dose ◽  
Concomitant Drug ◽  
Essential Medicine List ◽  
Single Dosage

Fixed dose combinations(FDC's) is a combination of 2 or more than 2 drugs in a single dosage formulations, it should not be confused with concomitant drug therapy which refers to taking 2 or more than 2 drugs separately. Fixed dose combinations may be rational or irrational. In India there are more FDC's than single drugs and majority of those FDC's are irrational. Many of these irrational FDC's are widely prescribed. The WHO essential medicine list incorporates only 23 FDC's while as the National list of essential medicines(NLEM) of 2011 has only 12 FDC's.

scholarly journals Interpretation of the changes in 2018 National Essential Medicine List (NEML) from the specialists

2019 ◽  
Vol 02 (02) ◽  
pp. 43-47
Author(s):  
Chuyu Li ◽  
Xinyao Pan ◽  
Wingting Leung ◽  
Zengshu Huang ◽  
Jing Zhou ◽  
...  
Keyword(s):  
Public Health ◽  
Health Insurance ◽  
Chinese Medicine ◽  
Chronic Diseases ◽  
Essential Medicine ◽  
Dosage Forms ◽  
Basic Drugs ◽  
Essential Medicine List ◽  
Drug List ◽  
The Difference

On 25 October 2018, National Essential Medicine List (NEML) of China was formally published by National Health Commission and it has been executed since 1 November. The new NEML, which includes 685 drugs with more than 1110 kinds of dosage forms and more than 1810 kinds of specifications, further standardizes dosage forms and specifications of drugs. The new catalog not only increases the number of categories, but also optimizes the structure of the drug list. It highlights the need for basic drugs in aspects of common diseases, chronic diseases, serious diseases and public health. Besides, the normalization of dosage forms and specifications, and the persistence of emphasizing the combination of Western and Chinese medicine are both the characteristics of it. This news report is composed of several parts including brief introduction of NEML, the difference between NEML and National Directory of Health Insurance (NDHI) which is likely to be confused with NEML, the dissection of the change of medicine varieties, relevant policies and potential issues of NEML. We intend to give a comprehensive interpretation of NEML from different perspectives.

Combination anti-hypertensives in WHO essential medicine list

The Lancet ◽  
2005 ◽  
Vol 366 (9486) ◽  
pp. 633-634 ◽  
Author(s):  
Madhur D Bhattarai
Keyword(s):  
Essential Medicine ◽  
Essential Medicine List

scholarly journals Prescription Pattern Analysis of Type II Diabetes Mellitus Inpatients and Associated Co-Morbidities

2020 ◽  
Vol 10 (3) ◽  
pp. 42-47
Author(s):  
Purnima Ashok ◽  
Vijesh Thollur Subrahmanian ◽  
Rinju Raj ◽  
Rahul Rajendra Babu ◽  
Ramshad T. P. ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Pattern Analysis ◽  
Essential Medicine ◽  
Type Ii Diabetes Mellitus ◽  
Hypoglycemic Agents ◽  
Type Ii ◽  
Oral Hypoglycemic Agents ◽  
Prescription Pattern ◽  
Essential Medicine List

Background: The present study was planned to assess the prescription pattern analysis of Type II Diabetes Mellitus and associated co-morbidities. As per WHO, the worldwide prevalence of DM will reach 366 million by 2030. Evaluating drug prescription pattern is a major aspect of patient care, which is used as a measure of the quality of care provided. Objectives: Primary objectives of the study were to highlight the current prescription pattern trends in patients having diabetes mellitus with or without other co-morbid conditions, to ensure safety and rational use of prescribed regimen. And the secondary objectives of the study were to analyse the demographic information of the enrolled patients and also to identify and analyse the prescriptions with polypharmacy. Materials and Methods: A prospective observational study was conducted to analyse the prescribing pattern of anti-diabetic drugs. The study incorporated 100 Type II DM inpatients having comorbid conditions. The study has been conducted with the help of WHO prescribing indicator scale. It is used to analyse drug class, generic and branded drugs, fixed dose combination and dosage form. Patient data was collected and medical data records were analysed daily till discharge from hospital. Results: It was found that most of the drugs have been prescribed are purely from Karnataka Essential Medicine list (KEML). And percentages of medicines prescribed on their generic name were 76%. About 51% of patients were treated only with oral hypoglycemic agents. Whereas, 38% were treated with Insulin and 11% were treated with both oral hypoglycemic agents and Insulin. Conclusion: Improved rational use of prescription by using Essential Medicine List (EML).And also ensured the appropriateness of prescription by using WHO scale. Several Adverse Drug Reactions (ADR)have been reported and which leads to improved  prescription pattern. Keywords: Type II Diabetes Mellitus, Prescribing Indicator, Co-Morbidities.

scholarly journals Morbidity profile and prescription audits using WHO core prescribing indicator in government hospitals of Province 1, Nepal

2021 ◽  
Vol 3 (2) ◽  
pp. 15-22
Author(s):  
Shambhu Shah ◽  
Prasanna Dahal ◽  
Anil Kumar Sah ◽  
Surya B. Parajuli ◽  
Naveen Shrestha
Keyword(s):  
Metabolic Diseases ◽  
Healthcare Delivery ◽  
Circulatory System ◽  
Essential Medicine ◽  
Cross Sectional Study ◽  
World Health ◽  
Healthcare Delivery System ◽  
Cross Sectional ◽  
Essential Medicine List ◽  
Tertiary Hospitals

Background: Periodic assessment of morbidity and drug use at various levels of healthcare delivery system is important to recognize common prevalent morbidities and rationalize the use of medicines. The study was conducted to determine the common morbidities and audit prescription using WHO prescribing indicator in government operated tertiary hospitals of eastern Nepal. Methods: A cross-sectional study was carried out in government tertiary hospitals of Province 1, Nepal, from March 2019 to August 2019. For analysis, descriptive statistics were used.  Prescribing characteristics were evaluated using recommended guidelines of the World Health Organization (WHO) prescribing indicators. Results: Six hundred prescriptions were analyzed. The most prevalent morbidity was endocrine, nutrition & metabolic diseases (21.5%) followed by diseases of the respiratory system (19.8%), circulatory system (17.6%), and digestive system (12.8%). The most frequently encountered individual disease entity were hypertension (18.7%), diabetes (15.5%), acid peptic disorders (14%). A total of 2072 drugs were prescribed with an average of 3.45 (± 1.39) drugs per consultation. About 30.2% of prescriptions encountered contain at least one antibiotics, whereas injectable were prescribed in 1.8%. Only 3.9% of total medicines were prescribed in generic name and 31.7% of drug prescribed were from essential medicine list. Conclusion: Among the prescriptions evaluated, diseases of the endocrine, respiratory, cardiovascular, and gastrointestinal systems were the most common morbidities. Polypharmacy was prevalent to some extent whereas prescribing in generic and essential medicine list was poor relative to standard WHO recommendations. However, the overall prescribing of antibiotics and injection were found to be satisfactory.

scholarly journals Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study

BMJ Open ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. e045262
Author(s):  
Michael Sergio Taglione ◽  
Nav Persaud
Keyword(s):  
Low Income ◽  
Essential Medicine ◽  
Cross Sectional Study ◽  
High Income ◽  
Essential Medicines ◽  
Low Income Countries ◽  
Cross Sectional ◽  
Essential Medicine List ◽  
Income Status ◽  
Essential Medicines Lists

ObjectiveEssential medicines lists have been created and used globally in countries that range from low-income to high-income status. The aim of this paper is to compare the essential medicines list of high-income countries with each other, the WHO’s Model List of Essential Medicines and the lists of countries of other income statuses.DesignHigh-income countries were defined by World Bank classification. High-income essential medicines lists were assessed for medicine inclusion and were compared with the subset of high-income countries, the WHO’s Model List and 137 national essential medicines lists. Medicine lists were obtained from the Global Essential Medicines database. Countries were subdivided by income status, and the groups’ most common medicines were compared. Select medicines and medicine classes were assessed for inclusion among high-income country lists.ResultsThe 21 high-income countries identified were most like each other when compared with other lists. They were more like upper middle-income countries and least like low-income countries. There was significant variability in the number of medicines on each list. Less than half (48%) of high-income countries included a newer diabetes medicines in their list. Most countries (71%) included naloxone while every country including at least one opioid medicine. More than half of the lists (52%) included a medicine that has been globally withdrawn or banned.ConclusionEssential medicines lists of high-income countries are similar to each other, but significant variations in essential medicine list composition and specifically the number of medications included were noted. Effective medicines were left off several countries’ lists, and globally recalled medicines were included on over half the lists. Comparing the essential medicines lists of countries within the same income status category can provide a useful subset of lists for policymakers and essential medicine list creators to use when creating or maintaining their lists.

scholarly journals PCASE4 HOW TO IMPLEMENT NATIONAL ESSENTIAL MEDICINE LIST IN SHANGHAI: PROS & CONS

2010 ◽  
Vol 13 (3) ◽  
pp. A218
Author(s):  
S Hu ◽  
YB Zhang ◽  
J He
Keyword(s):  
Essential Medicine ◽  
Essential Medicine List
Sign in / Sign up

Export Citation Format

Share Document